BioSig Technologies, Inc.
  • Home
  • About BioSig
    • Overview
    • Leadership
    • Partnerships
  • PURE EP
    • Our Solution
    • Publications
    • Physician Insights
  • Join Our Team
  • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Presentations
    • Events
    • Newsletter
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Fact Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy

February 7, 2023

BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments

January 19, 2023

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology

January 10, 2023

Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

December 14, 2022

BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology

December 6, 2022

BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology

October 24, 2022

BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022

October 12, 2022

BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base

October 7, 2022

BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module

September 22, 2022

BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth

August 30, 2022
rss_feed News RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...32
Next
Award
BioSig Technologies, Inc.
Sign Up for BioSig Updates Contact Us
Twitter linkedin Facebook
© 2023 BioSig Technologies, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap